Breast Cancer Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030

Breast Cancer Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030

Breast Cancer Diagnosis Trends and Forecast

The future of the global breast cancer diagnosis market looks promising with opportunities in the screening, diagnostic and predictive, prognostic, and research markets. The global breast cancer diagnosis market is expected to reach an estimated $9.2 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing incidence of breast cancer, technological advancements, and favorable reimbursement framework for breast cancer diagnosis.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Breast Cancer Diagnosis by Segment

The study includes a forecast for the global breast cancer diagnosis by type, product, application, end use industry, and region.

Breast Cancer Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Others

Breast Cancer Diagnosis Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Platform-based Products
• Instrument-based Products

Breast Cancer Diagnosis Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Screening
• Diagnostic and Predictive
• Prognostic
• Research

Breast Cancer Diagnosis Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers and Medical Laboratories
• Others

Breast Cancer Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Breast Cancer Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast cancer diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast cancer diagnosis companies profiled in this report include-

• Hologic
• Genomic Health
• Bd
• Danaher
• Koninklijke Philips
• Qiagen
• Thermo Fisher Scientific
• Myriad Genetics
• Argon Medical Devices
• F. Hoffmann-La Roche

Breast Cancer Diagnosis Market Insights

Lucintel forecasts that platform-based products is expected to witness higher growth over the forecast period due to the introduction of novel products and the growing preference for these innovations in targeted therapy.

Diagnostic and predictive will remain the largest segment due to the increasing trends of genetic testing.

APAC is expected to witness highest growth over the forecast period due to the growing incidence of breast cancer, increasing healthcare infrastructure, and rising adoption of advanced diagnostic techniques in the region.

Features of the Global Breast Cancer Diagnosis Market

Market Size Estimates: Breast cancer diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast cancer diagnosis market by various segments, such as by type, product, application, end use industry and region in terms of($B).

Regional Analysis: Breast cancer diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, products, applications, end use industries, and regions for the breast cancer diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast cancer diagnosis market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the breast cancer diagnosis market size?

Answer: The global breast cancer diagnosis market is expected to reach an estimated $9.2 billion by 2030.

Q.2 What is the growth forecast for breast cancer diagnosis market?

Answer: The global breast cancer diagnosis market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the breast cancer diagnosis market?

Answer: The major drivers for this market are increasing incidence of breast cancer, technological advancements, and favorable reimbursement framework for breast cancer diagnosis.

Q4. What are the major segments for breast cancer diagnosis market?

Answer: The future of the breast cancer diagnosis market looks promising with opportunities in the screening, diagnostic and predictive, prognostic, and research markets.

Q5. Who are the key breast cancer diagnosis market companies?

Answer: Some of the key breast cancer diagnosis companies are as follows:

• Hologic
• Genomic Health
• BD
• Danaher
• Koninklijke Philips
• QIAGEN
• Thermo Fisher Scientific
• Myriad Genetics
• Argon Medical Devices
• F. Hoffmann-La Roche

Q6. Which breast cancer diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that platform-based products is expected to witness higher growth over the forecast period due to the introduction of novel products and the growing preference for these innovations in targeted therapy.

Q7. In breast cancer diagnosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the growing incidence of breast cancer, increasing healthcare infrastructure, and rising adoption of advanced diagnostic techniques in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the breast cancer diagnosis market by type (imaging, biopsy, genomic tests, blood tests, and others), product (platform-based products and instrument-based products), application (screening, diagnostic and predictive, prognostic, and research ), end use industry (hospitals & clinics, diagnostic centers and medical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.